A new method of prostate biopsy has been introduced to the Chesterfield Royal Hospital that increases the chances of an accurate diagnosis whilst further reducing the risk of infection.
Until this week, the Royal only performed trans-rectal prostate biopsies, a procedure that carries a small risk of sepsis and can’t target the whole of the prostate. The Trust has just performed its first trans-perineal prostate biopsy, that reduces the risk of sepsis and can target the entire prostate to increase the likelihood of a cancer being detected.
Consultant Urologist and Prostate Cancer Lead Kate Linton said: “It’s much better for the patient because the risk of sepsis is reduced, it allows areas in the prostate to be targeted that in the past we would have struggled to target, and the procedure can be performed here under local anaesthetic as an outpatient”.
“The procedure has been around for a while and it’s been on our radar as we’ve been assessing whether or not it’s something we can feasibly provide here in Chesterfield. Initially centres were performing it under general anaesthetic and then moving to local anaesthetic, but the Covid-19 pandemic has had an impact as it’s reduced our access to general anaesthetic procedures. As we’ve become more reassured that performing this procedure under a local anaesthetic is feasible and acceptable to patients, we took steps to bring the procedure into our clinic and we’re delighted to be able to offer it as part of our diagnostic service.”
The procedure is carried out by Professor Rosario from Sheffield Teaching Hospitals who works at the Trust one day a week. He performed the procedure and will be training our other Consultants to be able to offer the procedure to a wider group of patients within Urology.